Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304190061> ?p ?o ?g. }
- W4304190061 endingPage "1669" @default.
- W4304190061 startingPage "1669" @default.
- W4304190061 abstract "Chagas disease is a tropical ailment indigenous to South America and caused by the protozoan parasite Trypanosoma cruzi, which has serious health consequences globally. Insect vectors transmit the parasite and, due to the lack of vaccine availability and limited treatment options, we implemented an integrated core proteomics analysis to design a reverse vaccine candidate based on immune epitopes for disease control. Firstly, T. cruzi core proteomics was used to identify immunodominant epitopes. Therefore, we designed the vaccine sequence to be non-allergic, antigenic, immunogenic, and to have better solubility. After predicting the tertiary structure, docking and molecular dynamics simulation (MDS) were performed with TLR4, MHC-I, and MHC-II receptors to discover the binding affinities. The final vaccine design demonstrated significant hydrogen bond interactions upon docking with TLR4, MHC-I, and MHC-II receptors. This indicated the efficacy of the vaccine candidate. A server-based immune simulation approach was generated to predict the efficacy. Significant structural compactness and binding stability were found based on MDS. Finally, by optimizing codons on Escherichia coli K12, a high GC content and CAI value were obtained, which were then incorporated into the cloning vector pET2+ (a). Thus, the developed vaccine sequence may be a viable therapy option for Chagas disease." @default.
- W4304190061 created "2022-10-11" @default.
- W4304190061 creator A5025988395 @default.
- W4304190061 creator A5033653339 @default.
- W4304190061 creator A5041142825 @default.
- W4304190061 creator A5053305087 @default.
- W4304190061 creator A5060396114 @default.
- W4304190061 creator A5063623320 @default.
- W4304190061 creator A5064594316 @default.
- W4304190061 creator A5090199210 @default.
- W4304190061 date "2022-10-07" @default.
- W4304190061 modified "2023-09-30" @default.
- W4304190061 title "Core Proteomics and Immunoinformatic Approaches to Design a Multiepitope Reverse Vaccine Candidate against Chagas Disease" @default.
- W4304190061 cites W1492813001 @default.
- W4304190061 cites W1497497378 @default.
- W4304190061 cites W1536886974 @default.
- W4304190061 cites W1552359986 @default.
- W4304190061 cites W1608392597 @default.
- W4304190061 cites W1896473474 @default.
- W4304190061 cites W1972043575 @default.
- W4304190061 cites W1973851226 @default.
- W4304190061 cites W1973980688 @default.
- W4304190061 cites W1977155815 @default.
- W4304190061 cites W1988789252 @default.
- W4304190061 cites W1988963904 @default.
- W4304190061 cites W1992192767 @default.
- W4304190061 cites W2001053206 @default.
- W4304190061 cites W2003805630 @default.
- W4304190061 cites W2014274241 @default.
- W4304190061 cites W2015176909 @default.
- W4304190061 cites W2019519304 @default.
- W4304190061 cites W2020719323 @default.
- W4304190061 cites W2025190578 @default.
- W4304190061 cites W2035240910 @default.
- W4304190061 cites W2048204856 @default.
- W4304190061 cites W2050717189 @default.
- W4304190061 cites W2051395326 @default.
- W4304190061 cites W2053538195 @default.
- W4304190061 cites W2053707749 @default.
- W4304190061 cites W2068843087 @default.
- W4304190061 cites W2069209078 @default.
- W4304190061 cites W2077701449 @default.
- W4304190061 cites W2102367710 @default.
- W4304190061 cites W2118817344 @default.
- W4304190061 cites W2119497560 @default.
- W4304190061 cites W2122732537 @default.
- W4304190061 cites W2127635589 @default.
- W4304190061 cites W2134967712 @default.
- W4304190061 cites W2141443728 @default.
- W4304190061 cites W2152770371 @default.
- W4304190061 cites W2154241726 @default.
- W4304190061 cites W2168036974 @default.
- W4304190061 cites W2170304291 @default.
- W4304190061 cites W2175098816 @default.
- W4304190061 cites W2189869403 @default.
- W4304190061 cites W2189959064 @default.
- W4304190061 cites W2267284177 @default.
- W4304190061 cites W2336315810 @default.
- W4304190061 cites W2425697116 @default.
- W4304190061 cites W2444393251 @default.
- W4304190061 cites W2487076382 @default.
- W4304190061 cites W2488219907 @default.
- W4304190061 cites W2562930371 @default.
- W4304190061 cites W2571850415 @default.
- W4304190061 cites W2588895177 @default.
- W4304190061 cites W2597129987 @default.
- W4304190061 cites W2600001751 @default.
- W4304190061 cites W2605557839 @default.
- W4304190061 cites W2620185010 @default.
- W4304190061 cites W2724154348 @default.
- W4304190061 cites W2744401611 @default.
- W4304190061 cites W2782788794 @default.
- W4304190061 cites W2783102765 @default.
- W4304190061 cites W2884557428 @default.
- W4304190061 cites W2905159884 @default.
- W4304190061 cites W2905211622 @default.
- W4304190061 cites W2908865574 @default.
- W4304190061 cites W2954792327 @default.
- W4304190061 cites W2982769959 @default.
- W4304190061 cites W2985338927 @default.
- W4304190061 cites W2992070886 @default.
- W4304190061 cites W2998232230 @default.
- W4304190061 cites W3007940623 @default.
- W4304190061 cites W3007974386 @default.
- W4304190061 cites W3022272785 @default.
- W4304190061 cites W3036820332 @default.
- W4304190061 cites W3082821167 @default.
- W4304190061 cites W3124411595 @default.
- W4304190061 cites W3163904779 @default.
- W4304190061 cites W3163965514 @default.
- W4304190061 cites W3184898819 @default.
- W4304190061 cites W4220801340 @default.
- W4304190061 cites W4224912682 @default.
- W4304190061 cites W4283074230 @default.
- W4304190061 cites W4285265754 @default.
- W4304190061 cites W4292883321 @default.
- W4304190061 cites W874529477 @default.
- W4304190061 doi "https://doi.org/10.3390/vaccines10101669" @default.